Preparation of controlled release nanodrug ibuprofen supported on mesoporous silica using supercritical carbon dioxide
Source abstract
Abstract
Deposition of ibuprofen (IBU) into ordered mesoporous silica SBA-15 was carried out to prepare controlled release nanodrug using supercritical carbon dioxide (scCO2) as solvent at 17 MPa and 310.15 K. The maximum drug loading of IBU/SBA-15 was as high as 41.96%. The characterization of the obtained materials was performed using x-ray diffractometry (XRD), scanning electron microscopy (SEM), and nitrogen (N2) adsorption-desorption isotherms; the results indicate that most adsorbed drugs were inside the nanoscale channels. The in vitro study shows that the time of complete (100%) release significantly decreases as drug-loading decreases. The interesting aspect is that the samples with similar drug loading display different release rates, which may be due to differences in the drug quantity adsorbed inside the pores. In addition, the modified Noyes-Whitney equation was used to model the release kinetics for all the samples and a good agreement was obtained between the model representation and experimental data. In addition, the solubility of IBU in scCO2was tested through a high-pressure view cell at the temperature range of 298.15–320.15 K and pressure range of 7–17 MPa. The experimental solubility data were well correlated using Chrastil’s equation as well as Mendez-Santiago and Teja’s equation.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Advanced ceramic materials synthesis · Aerogels and thermal insulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (29)
Show source-provided references
1. 10.1021/ie000339u10.1021/ie000339u ↗
2. 10.1016/j.cej.2007.07.07810.1016/j.cej.2007.07.078 ↗
3. 10.1021/ie00051a02010.1021/ie00051a020 ↗
4. Applications of supercritical fluid transport technology in preparation of controlled- release drug delivery systems
5. 10.1016/j.micromeso.2009.04.01310.1016/j.micromeso.2009.04.013 ↗
6. 10.1016/j.ces.2008.05.03110.1016/j.ces.2008.05.031 ↗
7. 10.1021/cm001155910.1021/cm0011559 ↗
8. 10.1016/j.jpba.2008.08.03110.1016/j.jpba.2008.08.031 ↗
9. 10.1016/j.addr.2007.10.01110.1016/j.addr.2007.10.011 ↗
10. 10.1021/j100212a04110.1021/j100212a041 ↗
11. 10.1016/j.supflu.2009.07.01210.1016/j.supflu.2009.07.012 ↗
12. 10.1016/S1387-1811(03)00339-110.1016/S1387-1811(03)00339-1 ↗
13. Supercritical fluids deposition techniques for the formation of nanocomposites
14. 10.1007/s10971-009-1932-310.1007/s10971-009-1932-3 ↗
15. Factors influencing the catalytic activity of SBA-15-supported copper nanoparticles in CO oxidation10.1016/j.apcata.2005.08.035 ↗
16. 10.1088/1742-6596/215/1/01208710.1088/1742-6596/215/1/012087 ↗
17. 10.1021/i160057a01110.1021/i160057a011 ↗
18. 10.1039/b821281c10.1039/b821281c ↗
19. 10.1016/j.supflu.2011.12.00810.1016/j.supflu.2011.12.008 ↗
20. 10.1016/j.supflu.2007.01.00710.1016/j.supflu.2007.01.007 ↗
21. 10.1016/j.cej.2009.10.01810.1016/j.cej.2009.10.018 ↗
22. 10.1016/j.jnoncrysol.2004.06.03110.1016/j.jnoncrysol.2004.06.031 ↗
23. Preparation, characterization and catalysis properties of Ag/SBA-15 nanocomposite by supercritical fluid deposition10.3724/SP.J.1077.2009.00129 ↗
24. 10.1016/j.ejpb.2003.12.00710.1016/j.ejpb.2003.12.007 ↗
25. 10.1016/j.supflu.2006.01.01310.1016/j.supflu.2006.01.013 ↗
26. Composite preparation of nano Cu/SBA-15 by supercritical fluid deposition
27. 10.1021/ie000151a10.1021/ie000151a ↗
28. Solubilization of polyalcohol in supercritical CO2 microemulsion10.3866/PKU.WHXB20110616 ↗
29. 10.1016/j.msec.2009.04.01210.1016/j.msec.2009.04.012 ↗